Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
17.88
+0.27 (1.53%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Kiniksa Pharmaceuticals Employees
Kiniksa Pharmaceuticals had 297 employees on December 31, 2023. The number of employees increased by 77 or 35.00% compared to the previous year.
Employees
297
Change (1Y)
77
Growth (1Y)
35.00%
Revenue / Employee
$1,016,067
Profits / Employee
$29,125
Market Cap
1.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 297 | 77 | 35.00% |
Dec 31, 2022 | 220 | 5 | 2.33% |
Dec 31, 2021 | 215 | 47 | 27.98% |
Dec 31, 2020 | 168 | 31 | 22.63% |
Dec 31, 2019 | 137 | 26 | 23.42% |
Dec 31, 2018 | 111 | 64 | 136.17% |
Dec 31, 2017 | 47 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
Omnicell | 3,650 |
Pacira BioSciences | 712 |
Ironwood Pharmaceuticals | 267 |
4D Molecular Therapeutics | 147 |
Pharvaris | 82 |
Verona Pharma | 79 |
Ligand Pharmaceuticals | 58 |
KNSA News
- 5 days ago - Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 11 days ago - Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 - GlobeNewsWire
- 26 days ago - Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals Provides Corporate Update - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution - GlobeNewsWire